Skip to main content
OpenTrials

Clinical trial condition

Purpura

Explore clinical trials studying Purpura. Study availability and eligibility vary by location and protocol.

378 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Purpura trial results

Completed

Evaluation of Glucocorticoids Plus Rituximab in Patients With Newly-Diagnosed or Relapsing IgA Vasculitis

NCT05329090

Conditions
Blood Coagulation Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Hopital La Cavale Blanche Brest, France
  • CHU Clermont Ferrand Clermont-Ferrand, France
  • CHU Clermont Ferrand Clermont-Ferrand, France
  • Hôpital Edouard Herriot Lyon, France
View all 14 locations
View Trial Details
Completed

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

NCT05369208

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Sobi Site 105 Toyohashi, Aichi-ken, Japan
  • Sobi Site 110 Tōon, Ehime, Japan
  • Sobi Site 118 Iizuka-shi, Fukuoka, Japan
  • Sobi Site 116 Kitakyushu, Fukuoka, Japan
View all 19 locations
View Trial Details
Completed

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

NCT04516967

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Site 112 Phoenix, Arizona, United States
  • Site 103 Long Beach, California, United States
  • Site 119 Orange, California, United States
  • Site 109 Sacramento, California, United States
View all 62 locations
View Trial Details
Completed

Phase III Study on HMPL-523 for Treatment of ITP

NCT05029635

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The First Affiliated hospital of USTC Hefei, Anhui, China
  • Beijing Chaoyang Hospital of Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 37 locations
View Trial Details
Completed

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

NCT04225156

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010037 Ocala, Florida, United States
  • Investigator Site 0010042 Iowa City, Iowa, United States
  • Investigator Site 0010040 Columbus, Ohio, United States
View all 87 locations
View Trial Details
Completed

A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

NCT03395210

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Bleeding and Clotting Disorders Institute- Site Number : 1087 Peoria, Illinois, United States
  • RCCA MC LLC- Site Number : 1091 Bethesda, Maryland, United States
  • Massachusetts General Hospital Cancer Center- Site Number : 1092 Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center- Site Number : 1099 Boston, Massachusetts, United States
View all 31 locations
View Trial Details

Related conditions